Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by BRUTUS1on May 17, 2019 11:25pm
43 Views
Post# 29757664

WTF basher scum here is the annual release from 31/07/2018

WTF basher scum here is the annual release from 31/07/2018now i c u bashing the always forgiving buddalover, but fuk you on her behalf you cocsukers, trying to say that was last years annuals for the 6th of june you lying peaces of shlt, here is the news release.

Isodiol International Inc. Reports Fiscal Year 2018 Audited Financial Results

C.ISOL 

 

VANCOUVER, British Columbia, July 30, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSEISOL) (OTCISOLD) (FSE:LB6A.F(the “Company” or “Isodiol”), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods, and the manufacturing of pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in Finished Pharmaceutical Products (FPPs), reports audited revenues for the Fiscal Year Ended March 31, 2018 of $19,137,266 compared to Fiscal Year Ended March 31, 2017 audited revenues of $355,959; a year-over-year increase of 5276%. 

“Although the Company experienced tremendous growth for its Fiscal Year 2018, we strongly believe that CBD is still in its infancy stage, and we are just beginning to understand its benefits for the human body,” said CEO of Isodiol, Marcos Agramont.  “Isodiol has made significant strategic acquisitions over the last 12 months that are just now beginning to bear fruit, and the Company is well positioned as a global leader in the manufacturing, distribution, and full commercialization of hemp-derived CBD products.”

Isodiol believes it has a strong balance sheet with $24,069,692 in cash and acquisition deposits, which are intended to facilitate continued growth throughout Fiscal Year 2019.  With positive changes in regulation that have affected the legality of hemp and CBD around the globe, the Company is expanding its worldwide sales force with the intention of capitalizing on the untapped market for API sales and Finished Pharmaceutical Products.

The Company incurred significant acquisition advisory and consulting costs during Fiscal Year 2018 that the Company deemed necessary to accomplish the following transactions:

Iso International LLC

Isodiol is the industry leader in hemp-derived phytocannabinoids. It produces 99%+ pure, natural nutraceutical- and pharmaceutical-grade bulk ingredients and nutraceutical consumer products for global distribution and direct-to-consumer sale.

Pot-O-Coffee

The Pot-O-Coffee product line consists of two coffee variants for cannabis infusion—one infused with cannabis plant-extracted tetrahydrocannabinol (THC) oil, while the other is infused with non-psychotropic cannabidiol (CBD) derived from agricultural based hemp oil.  Since the acquisition of the Pot-O-Coffee group of brands, Isodiol has been able to establish licensing relationships with Canopy Growth, Nutritional High, and a California manufacturer and anticipates further opportunities in the coming months.  The Company also has received product placements in select Winn-Dixie stores in select locations in the East Coast.


Read more at https://stockhouse.com/news/press-releases/2018/07/30/isodiol-international-inc-reports-fiscal-year-2018-audited-financial-results#owKOqkeieduwoCv6.99
Bullboard Posts